These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7693940)
1. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940 [TBL] [Abstract][Full Text] [Related]
2. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
3. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459 [TBL] [Abstract][Full Text] [Related]
4. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593 [TBL] [Abstract][Full Text] [Related]
6. Significance of antikeratin antibodies in rheumatoid arthritis. Hajiroussou VJ; Skingle J; Gillett AP; Webley M J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. Ordeig J; Guardia J J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364 [TBL] [Abstract][Full Text] [Related]
8. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
9. Prospect for an additional laboratory criterion for rheumatoid arthritis. von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Janssens X; Veys EM; Verbruggen G; Declercq L J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study. Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142 [TBL] [Abstract][Full Text] [Related]
13. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470 [TBL] [Abstract][Full Text] [Related]
14. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255 [TBL] [Abstract][Full Text] [Related]
15. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis. Genevay S; Hayem G; Verpillat P; Meyer O Ann Rheum Dis; 2002 Aug; 61(8):734-6. PubMed ID: 12117683 [TBL] [Abstract][Full Text] [Related]
16. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis. Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364 [TBL] [Abstract][Full Text] [Related]
17. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797 [TBL] [Abstract][Full Text] [Related]
18. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis? Zhao J; Liu X; Wang Z; Liu R; Li Z J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480 [TBL] [Abstract][Full Text] [Related]
19. [Specific antibodies for the early diagnosis of rheumatoid arthritis]. Li H; Li X; Gan X Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):20-4. PubMed ID: 11798731 [TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. A preliminary study. Vittecoq O; Jouen-Beades F; Krzanowska K; Bichon-Tauvel I; Ménard JF; Daragon A; Tron F; Le Loët X Joint Bone Spine; 2001 Mar; 68(2):144-53. PubMed ID: 11324930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]